The Enhanced Estimates and Analyses of the Updated Unmet Need Framework: Going Beyond the Basics
Resource updated 05/18/2021
Resource updated 05/18/2021
Resource updated 03/15/2023
Table linking HRSA HAB performance indicators to clinician training resources developed by HRSA programs.
Resource updated 01/31/2024
In this webinar, presenters reviewed the updated Unmet Need Framework for RWHAP Part A and B recipients and highlighted the difference between the required and enhanced estimates and analyses. Given that enhanced estimates and analyses are strongly encouraged by HRSA HAB, presenters discussed approaches to support recipients in expanding estimates and analyses.
These approaches will include possible linked databases to utilize for the estimates and the benefits of subpopulation analyses for understanding disparities in HIV care and treatment.
Resource updated 01/27/2021
Resource updated 09/19/2023
Resource updated 09/19/2023
Resource updated 02/11/2021
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Rapid has developed into a core feature of the Dorothy Mann Center HIV care continuum, assuring immediate linkage to expert HIV services, immediate initiation of therapy, and rapid viral suppression. Benefits are present for youth prevention services. Rapid access models are feasible and beneficial for youth HIV care and prevention.
Resource (Conference Presentation) updated 09/14/2023
Linkage Navigation Program provides an immediate connection to same-day medical care and medical case management services, promoting timely linkage to care and services, and tailored individualized care operationalizing initiatives such as Test N Treat and Test N PrEP with positive health outcomes for Ryan White clients.
Resource (Conference Presentation) updated 09/14/2023
Successes and lessons learned will be shared from three metropolitan areas on incorporating STI testing and treatment for prevention clients within an HIV medical home setting, along with how offering STI treatment impacts early identification service outcomes (e.g., HIV positivity rates, linkage to care referrals, and the rapid start of HIV treatment).
Resource (Conference Presentation) updated 09/14/2023
The Alabama Quality Management Group (AQMG) is a consortium of quality leaders representing all Alabama RWHAP Part C and D clinics, over 80% of Alabama's HIV-diagnosed population. Data for Care Alabama (D4C-AL), a CDC-funded retention-in-care project, uses risk-stratification based on missed visits. It is currently being implemented at one site but will continue to be implemented over time.
Resource (Conference Presentation) updated 09/14/2023
A clinic-based substance abuse screening and treatment program is described. Using the Screening, Brief Intervention, and Referral to Treatment model, this provides annual proactive screening of alcohol/drug use, with a brief provider response and a follow-up motivational interviewing brief intervention, with treatment provided by an embedded provider.
Resource (Conference Presentation) updated 09/14/2023
Oklahoma has been classified by the Department of Health and Human Services as one of the seven states with a high rural HIV burden. Test-and-treat protocols are feasible within high-volume HIV clinics which serve rural and underserved communities to minimize the time to the first appointment to decrease time to viral load suppression.
Resource (Conference Presentation) updated 09/14/2023
This session will share how three health departments created and cultivated a partnership that resulted in changes to Part A services administration and provision in the Washington, D.C., EMA.
Resource (Conference Presentation) updated 09/14/2023
This presentation will discuss the rapid antiretroviral treatment (ART) programs implemented at the University Health System in the San Antonio metropolitan area and the Baltimore City Health Department clinics, as well as preliminary results post-implementation, lessons learned, and plans for future quality improvement in both programs.
Resource (Conference Presentation) updated 09/14/2023
This session will focus on key findings and behavioral considerations for long-acting antiretroviral treatment (ART) HIV regimens, given the progress in research, development, and potential approval of these drugs. There will be a brief overview of the ATLAS and FLAIR studies, discussion of the medications, and an outline of the potential impact of the regimens on care delivery models, providers, patients, and payers if they are approved.
Resource (Conference Presentation) updated 09/14/2023